Table 2.
Evaluation of the prognostic significance of the parameters using the univariate analysis of variance.
| HR | 95% CI | p | |
|---|---|---|---|
| Age | 0.4629 | 0.2219–0.9657 | 0.168 |
| Sex (female/male) | 1.0748 | 0.5016–2.3032 | 0.852 |
| Tumor size | 1.6839 | 0.8512–3.3310 | 0.134 |
| Tumor localization (colon/rectum) | 0.4190 | 0.1707–1.0285 | 0.057 |
| Differentiation (well/other) | 0.0413 | 0.4811–2.2542 | 0.918 |
| Wall invasion (T) | 2.3222 | 1.1121–4.8501 | 0.02 |
| Lymph node invasion (yes/no) | 0.1312 | 0.0304–0.5661 | 0.006 |
| Metastasis (yes/no) | 6.4082 | 2.5226–16.2787 | 0.0001 |
| Stage | 3.6337 | 1.9390–6.8095 | 0.0001 |
| D-dimer | 2.1274 | 1.6926–2.6730 | <0.0001 |
| CEA | 1.0008 | 1.0014–1.0109 | 0.01 |
HR: hazard ratio; CI: confidence interval.